Janku Filip

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 79% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Janku Filip's trades of Monte Rosa Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
290.27
Quantity 38,899
Value US$4,711,101
Transaction date
Proposed sale
Price
22.29
Quantity 6,000
Value US$133,740
Transaction date
Proposed sale
Price
18.67
Quantity 11,845
Value US$221,146
Transaction date
Sale
Price
19.50
Quantity 9,189 -12.2%
Value US$179,161
Transaction date
Proposed sale
Price
19.50
Quantity 9,189
Value US$179,161
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-01 2026-06-30 PlS Planned sale
262 +35.4%
359.05
US$2,850,741
262 +35.4% 359.05 US$2,850,741
2026-06-30 2026-06-30 PrS Proposed sale
38,899
290.27
US$4,711,101
38,899 290.27 US$4,711,101
2026-06-30 2026-06-29 PlS Planned sale
9,175 +21.1%
331.97
US$464,383
9,175 +21.1% 331.97 US$464,383
2026-06-29 2026-06-29 PrS Proposed sale
6,000
22.29
US$133,740
6,000 22.29 US$133,740
2026-06-25 2026-06-24 PlS Planned sale
30,000 -33.3%
21.42
US$642,681
30,000 -33.3% 21.42 US$642,681
2026-06-24 2026-06-24 PrS Proposed sale
30,000
20.71
US$621,300
30,000 20.71 US$621,300
2026-06-25 2026-06-23 PlS Planned sale
11,845 -16.5%
20.22
US$239,522
11,845 -16.5% 20.22 US$239,522
2026-06-23 2026-06-23 PrS Proposed sale
11,845
18.67
US$221,146
11,845 18.67 US$221,146
2026-02-24 2026-02-23 S Sale
9,189 -12.2%
19.50
US$179,161
9,189 -12.2% 19.50 US$179,161
2026-02-23 2026-02-23 PrS Proposed sale
9,189
19.50
US$179,161
9,189 19.50 US$179,161
2026-01-05 2026-01-05 S Sale
3,155 -4.0%
15.17
US$47,861
3,155 -4.0% 15.17 US$47,861